SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001676568-16-000001
Filing Date
2016-06-14
Accepted
2016-06-14 16:18:26
Documents
2
Period of Report
2016-06-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1451
2 POWER OF ATTORNEY poa-krol.txt EX-24 4427
  Complete submission text file 0001676568-16-000001.txt   7309
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Issuer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARGOS THERAPEUTICS, INC. 4233 TECHNOLOGY DRIVE DURHAM NC 27704
Business Address
Krol Igor (Reporting) CIK: 0001676568 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35443 | Film No.: 161713229